Monday, April 11, 1994
CGNE cutting it close with tomato
With only a year of cash reserves, Calgene Inc. may not wait for the final go-ahead from the FDA before launching marketing of its Flavr Savr tomato.
"As far as I'm concerned, they've already said it's safe, with the report from the agency's Center for Food Safety and Applied Nutrition," Chairman and CEO Roger Salquist told BioCentury on Friday. "Anybody else involved in the chain is a paperpusher. I'm not saying we'll wait for final approval."